Small molecule inhibitors of the Candida albicans budded-to-hyphal transition act through multiple signaling pathways

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Midkiff, John ^a   Borochoff Porte, Nathan ^a   White, Dylan ^a   Johnson, Douglas I ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[2 [[2 [(2 AMINO 3 MERCAPTOPROPYL)AMINO] 3 METHYLPENTYL]OXY] 1 OXO 3 PHENYLPROPYL]AMINO] 4 (METHYLSULFONYL)BUTANOIC ACID ISOPROPYL ESTER; 2 CHLORO 5 NITROBENZANILIDE; 3 (3,5 DIBROMO 4 HYDROXYBENZYLIDENE) 1,3 DIHYDRO 5 IODO 2 INDOLONE; 3,4,5 TRIMETHOXYBENZOIC ACID 8 (DIETHYLAMINO)OCTYL ESTER; 5,8,11,14 ICOSATETRAYNOIC ACID; 7 CHLORO 5 (2 CHLOROPHENYL) 1,5 DIHYDRO 4,1 BENZOTHIAZEPIN 2(3H) ONE; A 3; AMOXAPINE; ANTIFUNGAL AGENT; BUDDED TO HYPHAL TRANSITION INHIBITOR; CALCINEURIN; CHLORPROMAZINE; CLOTIAPINE; CLOZAPINE; CLOZAPINE N OXIDE; FLUPERLAPINE; G PROTEIN COUPLED RECEPTOR; KETOTIFEN; LIFICIGUAT; LOXAPINE; MIRTAZAPINE; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; NIGERICIN; NORCLOZAPINE; PROTEIN CPH1 TRANSCRIPTION FACTOR; PROTEIN EFG1 TRANSCRIPTION FACTOR; PROTEIN KINASE INHIBITOR; REGULATOR PROTEIN; TACROLIMUS; UNCLASSIFIED DRUG; DRUG DERIVATIVE; METHIONINE;

ARTICLE; BUDDED TO HYPHAL TRANSITION; CALCIUM HOMEOSTASIS; CANDIDA ALBICANS; CONTROLLED STUDY; CULTURE MEDIUM; DRUG STRUCTURE; EPISTASIS; FUNGAL VIRULENCE; FUNGUS GROWTH; FUNGUS HYPHAE; GROWTH INHIBITION; INTRACELLULAR SIGNALING; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; SIGNAL TRANSDUCTION;

ARANEAE; CANDIDA ALBICANS;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CLOZAPINE; GENE EXPRESSION REGULATION, FUNGAL; HYPHAE; METHIONINE; SIGNAL TRANSDUCTION;

EID: 80053162338     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025395     Document Type: Article

References (66)

1. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, et al. (1999) Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 29: 239-244.
2. Warnock DW, (2007) Trends in the epidemiology of invasive fungal infections. Jpn J Med Mycol 48: 1-12.
3. Brown AJP, (2002) Expression of growth form-specific factors during morphogenesis in Candida albicans. pp. 87-93 Candida and Candidiasis, ed Calderone RA (ASM Press, Washington, D.C.).
4. Han T-L, Cannon RD, Villas-Bôas SG, (2011) The metabolic basis of Candida albicans morphogenesis and quorum sensing. Fungal Genet Biol doi:10.1016/j.fgb.2011.04.002.
5. Cottier F, Muhlschlegel FA, (2009) Sensing the environment: response of Candida albicans to the X factor. FEMS Microbiol Lett 295: 1-9.
6. Lee KL, Buckley HR, Campbell CC, (1975) An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida albicans. Sabouraudia 13: 148-153.
7. Liu H, Köhler J, Fink GR, (1994) Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science 266: 1723-1726.
8. Brown AJP, (2002) Morphogenetic signaling pathways in Candida albicans. pp. 95-106 Candida and Candidiasis, ed Calderone RA (ASM Press, Washington, D.C.).
9. Lengeler KB, Davidson RC, D'Souza C, Harashima T, Shen WC, et al. (2000) Signal transduction cascades regulating fungal development and virulence. Microbiol Mol Biol Rev 64 (4): 746-785.
10. Biswas S, Dijck PV, Datta A, (2007) Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol Mol Biol Rev 71: 348-376.
11. Feng QH, Summers E, Guo B, Fink G, (1999) Ras signaling is required for serum-induced hyphal differentiation in Candida albicans. J Bacteriol 181 (20): 6339-6346.
12. Shapiro RS, Uppuluri P, Zaas AK, Collins C, Senn H, et al. (2009) Hsp90 orchestrates temperature-dependent Candida albicans morphogenesis via Ras1-PKA signaling. Curr Biol 19: 621-629.
13. Csank C, Schröppel K, Leberer E, Harcus D, Mohamed O, et al. (1998) Roles of the Candida albicans mitogen-activated protein kinase homolog, Cek1p, in hyphal development and systemic candidiasis. Infect Immun 66 (6): 2713-2721.
14. Köhler JR, Fink GR, (1996) Candida albicans strains heterozygous and homozygous for mutations in mitogen-activated protein kinase signaling components have defects in hyphal development. Proc Natl Acad Sci USA 93 (23): 13223-13228.
15. Leberer E, Harcus D, Broadbent ID, Clark KL, Dignard D, et al. (1996) Signal transduction through homologs of the Ste20p and Ste7p protein kinases can trigger hyphal formation in the pathogenic fungus Candida albicans. Proc Natl Acad Sci USA 93 (23): 13217-13222.
16. Sonneborn A, Bockmuhl DP, Gerads M, Kurpanek K, Sanglard D, et al. (2000) Protein kinase A encoded by TPK2 regulates dimorphism of Candida albicans. Mol Microbiol 35: 386-396.
17. Stoldt VR, Sonneborn A, Leuker CE, Ernst JF, (1997) Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J 16: 1982-1991.
18. Braun BR, Johnson AD, (2000) TUP1, CPH1 and EFG1 make independent contributions to filamentation in Candida albicans. Genetics 155 (1): 57-67.
19. Miwa T, Takagi Y, Shinozaki M, Yun C-W, Schell WA, et al. (2004) Gpr1, a putative G-Protein-coupled receptor, regulates morphogenesis and hypha formation in the pathogenic fungus Candida albicans. Eukaryot Cell 3: 919-931.
20. Maidan MM, Thevelein JM, Dijck PV, (2005) Carbon source induced yeast-to-hypha transition in Candida albicans is dependent on the presence of amino acids and on the G-protein-coupled receptor Gpr1. Biochem Soc Trans 33: 291-293.
21. Sanchez-Martinez C, Perez-Martin J, (2002) Gpa2, a G-protein alpha subunit required for hyphal development in Candida albicans. Eukaryot Cell 1: 865-874.
22. Maidan MM, De Rop L, Serneels J, Exler S, Rupp S, et al. (2005) The G protein-coupled receptor Gpr1 and the Galpha protein Gpa2 act through the cAMP-protein kinase A pathway to induce morphogenesis in Candida albicans. Mol Biol Cell 16: 1971-1986.
23. Alvarez FJ, Konopka JB, (2007) Identification of an N-acetylglucosamine transporter that mediates hyphal induction in Candida albicans. Mol Biol Cell 18: 965-975.
24. Biswas S, Roy M, Datta A, (2003) N-acetylglucosamine-inducible CaGAP1 encodes a general amino acid permease which co-ordinates external nitrogen source response and morphogenesis in Candida albicans. Microbiology 149: 2597-2608.
25. Singh P, Ghosh S, Datta A, (2001) Attenuation of virulence and changes in morphology in Candida albicans by disruption of the N-acetylglucosamine catabolic pathway. Infec Immun 69 (12): 7898-7903.
26. Schweizer A, Rupp S, Taylor BN, Rollinghoff M, Schroppel K, (2000) The TEA/ATTS transcription factor CaTec1p regulates hyphal development and virulence in Candida albicans. Mol Microbiol 38 (3): 435-445.
27. Lane S, Zhou S, Pan T, Dai Q, Liu HP, (2001) The basic helix-loop-helix transcription factor Cph2 regulates hyphal development in Candida albicans partly via Tec1. Mol Cell Biol 21 (19): 6418-6428.
28. Lane S, Birse C, Zhou S, Matson R, Liu H, (2001) DNA array studies demonstrate convergent regulation of virulence factors by Cph1, Cph2, and Efg1 in Candida albicans. J Biol Chem 276: 48988-48996.
29. Kumamoto CA, (2008) Niche-specific gene expression during C. albicans infection. Curr Opin Microbiol 11: 325-330.
30. Davis D, Edwards JE Jr, Mitchell AP, Ibrahim AS, (2000) Candida albicans RIM101 pH response pathway is required for host-pathogen interactions. Infect Immun 68: 5953-5959.
31. Davis D, Wilson RB, Mitchell AP, (2000) RIM101-dependent and-independent pathways govern pH responses in Candida albicans. Mol Cell Biol 20: 971-978.
32. Braun BR, Kadosh D, Johnson AD, (2001) NRG1, a repressor of filamentous growth in C. albicans, is down-regulated during filament induction. EMBO J 20 (17): 4753-4761.
33. Kadosh D, Johnson AD, (2001) Rfg1, a protein related to the Saccharomyces cerevisiae hypoxic regulator Rox1, controls filamentous growth and virulence in Candida albicans. Mol Cell Biol 21 (7): 2496-2505.
34. Murad AMA, Leng P, Straffon M, Wishart J, Macaskill S, et al. (2001) NRG1 represses yeast-hypha morphogenesis and hypha-specific gene expression in Candida albicans. EMBO J 20 (17): 4742-4752.
35. Toenjes KA, Munsee SM, Ibrahim AS, Jeffrey RJEE Jr, et al. (2005) Small-molecule inhibitors of the budded-to-hyphal-form transition in the pathogenic yeast Candida albicans. Antimicrob Agents Chemother 49: 963-972.
36. Toenjes KA, Stark BC, Brooks KM, Johnson DI, (2009) Inhibitors of cellular signaling are cytotoxic or block the budded-to-hyphal transition in the pathogenic yeast Candida albicans. J Med Microbiol 58: 779-790.
37. Staab JF, Bahn Y-S, Sundstrom P, (2003) Integrative, multifunctional plasmids for hypha-specific or constitutive expression of green fluorescent protein in Candida albicans. Microbiology 149: 2977-2986.
38. Sharkey LL, McNemar MD, Saporito-Irwin SM, Sypherd PS, Fonzi WA, (1999) HWP1 functions in the morphological development of Candida albicans downstream of EFG1, TUP1, and RBF1. J Bacteriol 181: 5273-5279.
39. Sur C, Mallorga PJ, Wittmann M, Jacobson MA, Pascarella D, et al. (2003) N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl-D-aspartate receptor activity. Proc Natl Acad Sci USA 100: 13674-13679.
40. Gether U, (2000) Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocrine Rev 21: 90-113.
41. Bockmuhl DP, Ernst JF, (2001) A potential phosphorylation site for an A-type kinase in the Efg1 regulator protein contributes to hyphal morphogenesis of Candida albicans. Genetics 157 (4): 1523-1530.
42. Bockmuhl DP, Krishnamurthy S, Gerads M, Sonneborn A, Ernst JF, (2001) Distinct and redundant roles of the two protein kinase A isoforms Tpk1p and Tpk2p in morphogenesis and growth of Candida albicans. Mol Microbiol 42: 1243-1257.
43. Cox DA, Conforti L, Sperelakis N, Matlib MA, (1993) Selectivity of inhibition on Na+-Ca2+ exchange of heart mitochondria by benzothiazepine CGP-37157. J Cardiovasc Pharmacol 21: 595-599.
44. Kawamoto S, Hidaka H, (1984) 1-(5-Isoquinolinesulfonyl)-2-methylpiperazine (H-7) is a selective inhibitor of protein kinase C in rabbit platelets. Biochem Biophys Res Commun 125: 258-264.
45. Schreiber SL, Crabtree GR, (1992) The mechanism of action of cyclosporin A and FK506. Immunol Today 13: 136-142.
46. Chiou CY, Malagodi MH, (1975) Studies on the mechanism of action of a new Ca2+ antagonist, 8-(N,N-diethylamino)octyl 3,4,5-trimethoxybenzoate hydrochloride in smooth and skeletal muscles. Br J Pharmacol 53: 279-285.
47. Vercesi AE, Moreno SNJ, Bernardes CF, Meinicke AR, Fernandes EC, et al. (1993) Thapsigargin causes Ca2+ release and collapse of the membrane potential of Trypanosoma brucei mitochondria in situ and of isolated rat liver mitochondria. J Biol Chem 268: 8564-8568.
48. Cho H, Ueda M, Tamaoka M, Hamaguchi M, Aisaka K, et al. (1991) Novel caffeic acid derivatives: extremely potent inhibitors of 12-lipoxygenase. J Med Chem 34: 1503-1505.
49. Yecies LD, Johnson SM, Wedner HJ, Parker CW, (1979) Slow reacting substance (SRS) from ionophore A23187-stimulated peritoneal mast cells of the normal rat. II. Evidence for a precursor role of arachidonic acid and further purification. J Immun 122: 2090-2095.
50. Dreyer C, Keller H, Mahfoudi A, Laudet V, Krey G, et al. (1993) Positive regulation of the peroxisomal beta-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors (PPAR). Biol Cell 77: 67-76.
51. Keller H, Dreyer C, Medin J, Mahfoudi A, Ozato K, et al. (1993) Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci USA 90: 2160-2164.
52. Berger J, Moller DE, (2002) The mechanisms of action of PPARs. Annu Rev Med 53: 409-435.
53. Maccarrone M, Zadelhoff GV, Veldink GA, Vliegenthart JFG, Finazzi-Agro A, (2000) Early activation of lipoxygenase in lentil (Lens culinaris) root protoplasts by oxidative stress induces programmed cell death. Eur J Biochem 267: 5078-5084.
54. Takami M, Preston SL, Behrman HR, (2000) Eicosatetraynoic and eicosatriynoic acids, lipoxygenase inhibitors, block meiosis via antioxidant action. Am J Physiol Cell Physiol 278: C646-C650.
55. Hornby JM, Jensen EC, Lisec AD, Tasto JJ, Jahnke B, et al. (2001) Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl Environ Microbiol 67: 2982-2992.
56. Davis-Hanna A, Piispanen AE, Stateva LI, Hogan DA, (2008) Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesis. Mol Microbiol 67: 47-62.
57. Noverr MC, Erb-Downward JR, Huffnagle GB, (2003) Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes. Clin Microbiol Rev 16: 517-533.
58. Alem MAS, Douglas LJ, (2005) Prostaglandin production during growth of Candida albicans biofilms. J Med Microbiol 54: 1001-1005.
59. Brodhun F, Feussner I, (2011) Oxylipins in fungi. FEBS Journal 278: 1047-1063.
60. Singh A, Poeta MD, (2011) Lipid signaling in pathogenic fungi. Cell Microbiol 13: 177-185.
61. Inagaki M, Kawamoto S, Itoh H, Saitoh M, Hagiwara M, et al. (1986) Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors. Mol Pharmacol 29: 577-581.
62. Barrington RE, Subler MA, Rands E, Omer CA, Miller PJ, et al. (1998) A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis. Mol Cell Biol 18: 85-92.
63. Lackey K, Cory M, Davis R, Frye SV, Harris PA, et al. (2000) The discovery of potent cRaf1 kinase inhibitors. Bioorg Med Chem Lett 10: 223-226.
64. Birse CE, Irwin MY, Fonzi WA, Sypherd PS, (1993) Cloning and characterization of ECE1, a gene expressed in association with cell elongation of the dimorphic pathogen Candida albicans. Infec Immun 61: 3648-3655.
65. Sherman F, Fink GR, Hicks JB, (1986) Methods in yeast genetics: Laboratory manual. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.).
66. Gillum AM, Tsay EY, Kirsch DR, (1984) Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198: 179-182.